Forte Biosciences, Inc.
FBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35 | -$31 | -$14 | -$22 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3 | $3 | $4 | $0 |
| Change in WC | $2 | -$0 | $2 | $1 |
| Other Non-Cash | -$0 | -$0 | $0 | $4 |
| Operating Cash Flow | -$31 | -$29 | -$8 | -$17 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$36 | -$10 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $10 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$36 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $53 | $25 | $7 | $0 |
| Stock Repurch. | -$0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$0 | $0 | -$0 |
| Financing Cash Flow | $52 | $25 | $7 | -$0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$4 | -$1 | -$17 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $41 | $42 | $59 |
| End Cash | $22 | $37 | $41 | $42 |
| Free Cash Flow | -$31 | -$29 | -$8 | -$17 |